A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05.
Hiroshi HaginoT SugimotoShiro TanakaK SasakiT SoneT NakamuraSatoshi SoenSatoshi MoriPublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2021)
jRCTs031180235 and UMIN000015573, March 12, 2019.